@prefix dcterms: <http://purl.org/dc/terms/> .
@prefix ns1: <http://purl.org/spar/pro/> .
@prefix ns2: <http://purl.org/spar/datacite/> .
@prefix ns3: <http://purl.org/vocab/frbr/core#> .
@prefix ns4: <http://prismstandard.org/namespaces/basic/2.0/> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<> dcterms:license <https://creativecommons.org/publicdomain/zero/1.0/legalcode> .

<https://w3id.org/oc/meta/br/0607915411> a <http://purl.org/spar/fabio/Expression>,
        <http://purl.org/spar/fabio/JournalArticle> ;
    rdfs:label "br 0607915411" ;
    ns4:publicationDate "2024-12-07"^^xsd:date ;
    dcterms:title "The Endocannabinoid Activity Remodulation For Psychosis Liability In Youth (EARLY) Study: An Open-Label Feasibility Trial Of Ultramicronized-Palmitoylethanolamide Oral Supplementation In Clinical High-Risk State For Psychosis" ;
    ns2:hasIdentifier <https://w3id.org/oc/meta/id/06022629276>,
        <https://w3id.org/oc/meta/id/0607200091> ;
    ns1:isDocumentContextFor <https://w3id.org/oc/meta/ar/06027875511>,
        <https://w3id.org/oc/meta/ar/06027875512>,
        <https://w3id.org/oc/meta/ar/06027875513>,
        <https://w3id.org/oc/meta/ar/06027875514>,
        <https://w3id.org/oc/meta/ar/06027875515>,
        <https://w3id.org/oc/meta/ar/06027875516>,
        <https://w3id.org/oc/meta/ar/06027875517>,
        <https://w3id.org/oc/meta/ar/06027875518>,
        <https://w3id.org/oc/meta/ar/06027875519>,
        <https://w3id.org/oc/meta/ar/06027875520>,
        <https://w3id.org/oc/meta/ar/06027875521> ;
    ns3:embodiment <https://w3id.org/oc/meta/re/0604077051> ;
    ns3:partOf <https://w3id.org/oc/meta/br/06404753952> .